SA PRO
Free Account
Themes
DexCom, Inc.DXCMNASDAQ
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts lean bullish — 92% recommend buying.

Consensus Rating
Buy
25 analysts·High coverage
92%
Rating Distribution
Strong Buy
14%
Buy
2288%
Hold
14%
Sell
14%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 18% higher.

Bear Case
$72.00
-1%
Consensus
$85.82
+18%
Bull Case
$95.00
+30%
Price Range25 analysts
Low
Consensus
High
$72.00
$95.00
Current Target
Current Price
$72.90
Upside to Target
$12.92

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 13, 2026Robert W. Baird
DexCom price target raised to $87 from $82 at Baird
Target:$87.00
+23.1%from $70.67
Feb 13, 2026Mizuho Securities
DexCom price target raised to $90 from $78 at Mizuho
Target:$90.00
+38.3%from $65.08
Feb 13, 2026Canaccord Genuity
DexCom price target lowered to $95 from $99 at Canaccord
Target:$95.00
+46.0%from $65.08
Feb 13, 2026Barclays
DexCom price target raised to $72 from $71 at Barclays
Target:$72.00
+10.6%from $65.08
Jan 12, 2026Barclays
Barclays downgrades DexCom to Underweight on rising competition
Target:$71.00
+1.9%from $69.67
Jan 9, 2026Bernstein
DexCom price target raised to $86 from $84 at Bernstein
Target:$86.00
+25.7%from $68.43
Dec 17, 2025Mizuho Securities
DexCom price target raised to $78 from $75 at Mizuho
Target:$78.00
+17.5%from $66.37
Dec 16, 2025Leerink Partners
DexCom (DXCM) PT Raised to $92 at Leerink Partners
Target:$92.00
+40.7%from $65.38
Dec 2, 2025Morgan Stanley
DexCom upgraded to Overweight from Equal Weight at Morgan Stanley
Target:$75.00
+18.1%from $63.52
Nov 10, 2025Morgan Stanley
DexCom price target lowered to $63 from $89 at Morgan Stanley
Target:$63.00
+14.1%from $55.21
Nov 3, 2025Bernstein
'DexCom (DXCM) Too Cheap to Ignore'; Stock PT Lowered at Bernstein
Target:$84.00
+44.3%from $58.22
Nov 3, 2025Barclays
DexCom price target lowered to $80 from $98 at Barclays
Target:$80.00
+37.4%from $58.22
Oct 31, 2025Piper Sandler
DexCom (DXCM) PT Lowered at Piper Sandler; 'We Strongly Recommend Investors Buy the Stock'
Target:$75.00
+31.6%from $56.97
Oct 31, 2025RBC Capital
DexCom price target lowered to $85 from $100 at RBC Capital
Target:$85.00
+49.3%from $56.95
Oct 31, 2025Robert W. Baird
DexCom price target lowered to $82 from $90 at Baird
Target:$82.00
+38.5%from $59.19
Oct 31, 2025Wells Fargo
DexCom price target lowered to $93 from $98 at Wells Fargo
Target:$93.00
+36.4%from $68.20
Oct 31, 2025Canaccord Genuity
DexCom price target lowered to $99 from $106 at Canaccord
Target:$99.00
+45.2%from $68.20
Oct 21, 2025Piper Sandler
Piper Sandler Sees Good Setup for DexCom (DXCM) Stock, Recommends Purchase
Target:$100.00
+46.1%from $68.44
Oct 15, 2025Truist Financial
DexCom price target lowered to $94 from $102 at Truist
Target:$94.00
+43.4%from $65.55
Sep 26, 2025Robert W. Baird
DexCom price target lowered to $90 from $112 at Baird
Target:$90.00
+31.8%from $68.30
Oct 8, 2024RBC Capital
DexCom price target lowered to $120 from $130 at RBC Capital
Target:$120.00
+74.9%from $68.62
Aug 22, 2024Stifel Nicolaus
DexCom price target raised to $100 from $90 at Stifel
Target:$100.00
+38.4%from $72.28
Aug 16, 2024RBC Capital
DexCom price target lowered to $130 from $145 at RBC Capital
Target:$130.00
+79.7%from $72.36
Jul 29, 2024Barclays
DexCom price target lowered to $113 from $138 at Barclays
Target:$113.00
+76.6%from $64.00
Jul 26, 2024Oppenheimer
DexCom price target lowered to $115 from $150 at Oppenheimer
Target:$115.00
+6.6%from $107.85

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance